|ECHA InfoCard||Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).|
|Except where noted otherwise, data are given for|
materials in their standard state
(at 25 °C, 100 kPa)
Infobox disclaimer and references
CX516 is an ampakine compound that works as an AMPA modulator and is being devolped by a collaboration of Cortex and Shire and Servier. It is being pursued as a treatment for Alzheimer's disease, under the brand name Ampalex. It is also being examined as a treatment for ADHD. The CAS number of this compound is 154235-83-3.